Cargando…

Circulating tumor necrosis factor‐α, interleukin‐1β, and interleukin‐17A estimates increased major adverse cardiac event risk in acute myocardial infarction patients

BACKGROUND: Inflammatory cytokines are implicated in the development of atherosclerosis and cardiomyocyte injury during acute myocardial infarction (AMI). This study aimed to investigate the correlation of eight common inflammatory cytokines with major adverse cardiac event (MACE) risk and further e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Jing, Hu, Zhenfeng, Ren, Liang, Zhao, Weibo, Zuo, Ruijing, Guo, Shuang, Jia, Chaoguo, Gao, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098063/ https://www.ncbi.nlm.nih.gov/pubmed/36877748 http://dx.doi.org/10.1002/jcla.24853

Ejemplares similares

Soluble interleukin-2 receptor combined with interleukin-8 is a powerful predictor of future adverse cardiovascular events in patients with acute myocardial infarction
por: Pan, Kunming, et al.
Publicado: (2023)

Brain Interleukin-17A contributes to neuroinflammation and cardiac dysfunction in rats with myocardial infarction
por: Yu, Yang, et al.
Publicado: (2022)

Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis
por: Kaczyński, Tomasz, et al.
Publicado: (2019)

Relation of interleukin-6 levels in COVID-19 patients with major adverse cardiac events
por: Nguyen, Nicholas, et al.
Publicado: (2021)

Effect of Interleukin-17 in the Activation of Monocyte Subsets in Patients with ST-Segment Elevation Myocardial Infarction
por: Garza-Reyes, Montserrat Guadalupe, et al.
Publicado: (2020)

Expansion of CD4 T Lymphocytes Expressing Interleukin 17 and Tumor Necrosis Factor in Patients with Major Depressive Disorder
por: Alvarez-Mon, Miguel Angel, et al.
Publicado: (2021)

Early kinetics of serum Interleukine-17A and infarct size in patients with reperfused acute ST-elevated myocardial infarction
por: Bochaton, Thomas, et al.
Publicado: (2017)

The interleukin-1 cluster, dyslipidaemia and risk of myocardial infarction
por: Keavney, Bernard
Publicado: (2010)

Interleukin-6 gene −572 G > C polymorphism and myocardial infarction risk
por: Ding, He-guo, et al.
Publicado: (2020)

Circulating Platelet-Derived Microparticles Associated with Postdischarge Major Adverse Cardiac Events in ST-Elevation Acute Myocardial Infarction
por: Hartopo, Anggoro Budi, et al.
Publicado: (2020)

Interleukin-17A and interleukin-23 in morphea
por: Dańczak-Pazdrowska, Aleksandra, et al.
Publicado: (2012)

Out of the shadow of interleukin-17A: the role of interleukin-17F and other interleukin-17 family cytokines in spondyloarthritis
por: Yeremenko, Nataliya
Publicado: (2021)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
por: Zheng, Meifan, et al.
Publicado: (2020)

High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
por: Tøllefsen, Ingvild Maria, et al.
Publicado: (2021)

I-Kappa-B-Zeta Regulates Interleukin-17A/Tumor Necrosis Factor-Alpha Mediated Synergistic Induction of Interleukin-19 and Interleukin-20 in Humane Keratinocytes
por: Bertelsen, Trine, et al.
Publicado: (2021)

Interleukin‐38 alleviates cardiac remodelling after myocardial infarction
por: Wei, Yuzhen, et al.
Publicado: (2019)

The role of Interleukin-17A and Interleukin-17E in multiple myeloma patients
por: Lemancewicz, Dorota, et al.
Publicado: (2012)

Prevalence and association of medication nonadherence with major adverse cardiovascular events in patients with myocardial infarction
por: Hou, Yunfeng, et al.
Publicado: (2019)

The Role of Interleukin-17 in Lung Cancer
por: Wu, Feng, et al.
Publicado: (2016)

Systematic Review and Meta-Analysis of Inflammatory Bowel Disease Adverse Events with Anti-Interleukin 17A Agents and Tumor Necrosis Factor Inhibitors in Rheumatic Disease and Skin Psoriasis
por: Truong, Steven L., et al.
Publicado: (2021)

Interleukin-17 and Interleukin-10 Association with Disease Progression in Schizophrenia
por: Chenniappan, Raghavi, et al.
Publicado: (2020)

Association of genetic polymorphism of interleukin-17A & interleukin-17F with susceptibility of psoriasis
por: Kaur, Rajinder, et al.
Publicado: (2018)

Serum interleukin 17A and interleukin 17F in children with inflammatory bowel disease
por: Krawiec, Paulina, et al.
Publicado: (2020)

ELEVATED INTERLEUKIN-6 LEVELS IN COVID-19-INFECTED PATIENTS ARE ASSOCIATED WITH MAJOR ADVERSE CARDIAC EVENTS AND/OR MORTALITY
por: Nguyen, Nicholas, et al.
Publicado: (2021)

Elevated plasma levels of interleukin-16 in patients with acute myocardial infarction
por: Schernthaner, Christiana, et al.
Publicado: (2017)

Alterations in the Interleukin-1/Interleukin-1 Receptor Antagonist Balance Modulate Cardiac Remodeling following Myocardial Infarction in the Mouse
por: Abbate, Antonio, et al.
Publicado: (2011)

Targeting interleukin-17 receptors
por: Lee, Wen-Hwa, et al.
Publicado: (2015)

Roles of interleukin-17 in uveitis
por: Guedes, Marta Catarina Esteves, et al.
Publicado: (2016)

Interleukin-17 in Antifungal Immunity
por: Sparber, Florian, et al.
Publicado: (2019)

Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
por: Attar, Rubina, et al.
Publicado: (2020)

Interleukin 35 regulates interleukin 17 expression and T helper 17 in patients with proliferative diabetic retinopathy
por: Yan, Ai, et al.
Publicado: (2022)

Rheumatoid synovial fluid interleukin-17-producing CD4 T cells have abundant tumor necrosis factor-alpha co-expression, but little interleukin-22 and interleukin-23R expression
por: Church, Leigh D, et al.
Publicado: (2010)

Serum tumor necrosis factor‐α, interleukin‐1β, interleukin‐6, and interleukin‐17 relate to anxiety and depression risks to some extent in non‐small cell lung cancer survivor
por: Liu, Meifang, et al.
Publicado: (2021)

Interleukin – 17 and Interleukin-10 as Inflammatory and Prevention Biomarkers in Periimplant Diseases
por: Farhad, Shirin Zahra, et al.
Publicado: (2019)

Analysis of interleukin-17 and interleukin-18 levels in animal models of atherosclerosis
por: Tang, Xiuming
Publicado: (2019)

Interleukin-17 (IL-17) Expression Is Reduced during Acute Myocardial Infarction: Role on Chemokine Receptor Expression in Monocytes and Their in Vitro Chemotaxis towards Chemokines
por: Troitskaya, Maria, et al.
Publicado: (2012)

Interleukin‐37 and Dendritic Cells Treated With Interleukin‐37 Plus Troponin I Ameliorate Cardiac Remodeling After Myocardial Infarction
por: Zhu, Ruirui, et al.
Publicado: (2016)

Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma
Publicado: (1989)

Stress hyperglycemia ratio: an independent predictor for in-hospital major adverse cardiovascular and cerebrovascular events in patients with st-segment elevation myocardial infarction
por: Guo, Wen, et al.
Publicado: (2023)

Association Between Medication Adherence and 1‐Year Major Cardiovascular Adverse Events After Acute Myocardial Infarction in China
por: Shang, Pu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5godej3k6jpkglf6v5t181pmat